18 result(s) have been found!
| Accession | Name | Sequence | Source/Organism | Mechanism | Assay Type | Cell Line | Cancer Type | Activity |
|---|---|---|---|---|---|---|---|---|
| dbacp01844 | BLP-7 | GIGGALLSAGKSALKGLAKGLAEHFAN | Oriental Fire-bellied Toad | Cell membrane Permeabilization | MTT assay | SK-HEP-1 | Human hepatoma | IC50 : 0.61μM |
| dbacp01852 | Bombina orientalis Bombinin H-BO1 | IIGPVLGLVGKALGGLL | Oriental Fire-bellied Toad Bombinin H-BO1 | Anti-proliferative effects | MTT assay | SK-HEP-1 | Human hepatoma | IC50 : 8.08 μM |
| dbacp01855 | Bombina orientalis Bombinin H-BO4 | GIGSAILSAGKSIIKGLAKGLAEHF | Oriental Fire-bellied Toad Bombinin H-BO1 | Anti-proliferative effects | MTT assay | SK-HEP-1 | Human hepatoma | IC50 : 8.08 μM |
| dbacp01858 | Bombinin H-BO | IIGPVLGLIGKALGGLL | Oriental Fire-bellied Toad | Cell Membrane Permeabilization | MTT assay | SK-HEP-1 | Human hepatoma | IC50 : 1.81 μM |
| dbacp01861 | Bombinin H-BO1 | IIGPVLGLVGKALGGLL | Oriental Fire-bellied Toad | Anti-proliferative effects | MTT assay | SK-HEP-1 | Human hepatoma | IC50 : 8.08 μM |
| dbacp01864 | Bombinin H-BO1 | IIGPVLGLVGKALGGLL | Skin secretion, Oriental fire-bellied toad, China, Asia | Anti-proliferative effects | MTT assay | SK-HEP-1 | Human hepatoma cancer | IC50 : 8.08 μM |
| dbacp01868 | Bombinin-BO1 | GIGSAILSAGKSIIKGLAKGLAEHF | Oriental Fire-bellied Toad | Anti-proliferative effects | MTT assay | SK-HEP-1 | Human hepatoma | IC50 : 8.08 μM |
| dbacp01871 | Bombinin-BO1 | GIGSAILSAGKSIIKGLAKGLAEHF | Skin secretion, Oriental fire-bellied toad, China, Asia | Anti-proliferative effects | MTT assay | SK-HEP-1 | Human hepatoma cancer | IC50 : 3.75 μM |
| dbacp01874 | Bombinins BLP-7 GH-2 [Cleaved into: Bombinin-like peptide 7 (BLP-7); Bombinin GH-2] | MNFKYIVAVSFLIASTYARSVKNDEQSLSQRDVLEEESLREIRGIGGALLSAGKSALKGLAKGLAEHFANGKRTAEEHEVMKRLEAVMRDLDSLDYPEEASEMETRSFNQEEIANLFTKKEKRILGPVLDLVGRALRGLLKKIG | Oriental fire-bellied toad | Anti-proliferative action | MTT assay | SK-HEP-1 cells | Human hepatoma | IC50 : 0.61 μM |
| dbacp01875 | Bombinins BLP-7 GH-2 [Cleaved into: Bombinin-like peptide 7 (BLP-7); Bombinin GH-2] | MNFKYIVAVSFLIASTYARSVKNDEQSLSQRDVLEEESLREIRGIGGALLSAGKSALKGLAKGLAEHFANGKRTAEEHEVMKRLEAVMRDLDSLDYPEEASEMETRSFNQEEIANLFTKKEKRILGPVLDLVGRALRGLLKKIG | Oriental fire-bellied toad | Anti-proliferative action | MTT assay | SK-HEP-1 cells | Human hepatoma | IC50 : 0.99 μM |
| dbacp01880 | Bombinins BLP-7 H-BO [Cleaved into: Bombinin-like peptide 7 (BLP-7); Bombinin H-BO] | MNFKYIIAVSFLIASTYARSVKNDEQSLSQRDVLDEESLREIRGIGGALLSAGKSALKGLAKGLAEHFANGKRTAEEHEVMKRLEAVMRDLDSLDHPEEASEKETRGFNQEEIANLFTKKEKRIIGPVLGLIGKALGGLLG | Oriental fire-bellied toad | Not specified | MTT assay | SK-HEP-1 | Human hepatoma | IC50 : 0.61 μM |
| dbacp01881 | Bombinins BLP-7 H-BO [Cleaved into: Bombinin-like peptide 7 (BLP-7); Bombinin H-BO] | MNFKYIIAVSFLIASTYARSVKNDEQSLSQRDVLDEESLREIRGIGGALLSAGKSALKGLAKGLAEHFANGKRTAEEHEVMKRLEAVMRDLDSLDHPEEASEKETRGFNQEEIANLFTKKEKRIIGPVLGLIGKALGGLLG | Oriental fire-bellied toad | Not specified | MTT assay | SK-HEP-1 | Human hepatoma | IC50 : 0.99 μM |
| dbacp01887 | Bombinins BLP-7/GH-2 | MNFKYIVAVSFLIASTYARSVKNDEQSLSQRDVLEEESLREIRGIGGALLSAGKSALKGLAKGLAEHFANGKRTAEEHEVMKRLEAVMRDLDSLDYPEEASEMETRSFNQEEIANLFTKKEKRILGPVLDLVGRALRGLLKKIG | Oriental fire-bellied toad | Anti-proliferative activity | In vitro antitumor assay | SK-HEP-1 | Human hepatoma | IC50 : 0.99 μM |
| dbacp01890 | Bombinins BLP-7/H-BO | MNFKYIIAVSFLIASTYARSVKNDEQSLSQRDVLDEESLREIRGIGGALLSAGKSALKGLAKGLAEHFANGKRTAEEHEVMKRLEAVMRDLDSLDHPEEASEKETRGFNQEEIANLFTKKEKRIIGPVLGLIGKALGGLLG | Oriental fire-bellied toad | Anti-proliferative activity | In vitro antitumor assay | SK-HEP-1 | Human hepatoma | IC50 : 0.99 μM |
| dbacp07401 | NMTP-5 | zffygwyggmekllrggrgerppr | Not Available | NRP1/MDM2 inhibition induces apoptosis | MTT assay | SK-HEP-1 | Liver Cancer | IC50 = 53.84 ± 4.35 µM |
| dbacp07477 | (LLKK)4 linear peptide | LLKKLLKKLLKKLLKK | Synthetic | Apoptosis, drug-resistance reversal, tumor suppression | MTT assay | SK-HEP-1 | Liver Cancer | Cell Viability (%) ~ 14.1 ± 0.8 at 30 µg/mL |
| dbacp07481 | 2-arm branched peptide | [LLKKLLKK]2kC | Synthetic | Apoptosis, drug-resistance reversal, tumor suppression | MTT assay | SK-HEP-1 | Liver Cancer | Cell Viability (%) ~ 85.7 ± 4.3 at 30 µg/mL |
| dbacp07485 | 4-arm branched peptide | {[LLKKLLKK]2kC}2 | Synthetic | Apoptosis, drug-resistance reversal, tumor suppression | MTT assay | SK-HEP-1 | Liver Cancer | Cell Viability (%) ~ 31.7 ± 5.1 at 30 µg/mL |